Cancer Prevention and Research Institute of Texas

ESSA Pharma receives $4M from Research Institute of Texas

Wednesday, February 1, 2017

ESSA Pharma, a pharmaceutical company, currently in the clinical development stage, focused on the development of small molecule drugs for the treatment of prostate cancer, announced the receipt of a $4 million payment from the Cancer Prevention Research Institute of Texas (CPRIT). The payment is part of a total non-dilutive grant of $12 million, repayable out of potential product revenues, which was originally awarded in February 29, 2014.

[Read More]

Pediatric Cancer Foundation to honor Congressmen McCaul & Van Hollen

Wednesday, September 21, 2016

Congressman Michael Mccaul and Congressman Chris Van Hollen to be honored at the 3rd Annual Golden Toast. The Golden Toast represents bipartisan politics at its finest. It is an evening when members of Congress from both sides of the aisle demonstrate a commitment to some of the most vulnerable members of society—children who are fighting cancer. In an election season marked by divisiveness, the Golden Toast is a visible reminder that our elected officials can put aside disagreements to accomplish meaningful change and advance life-saving research. 

[Read More]